title: Activation of ErbB2- ErbB3 signaling pathway supports potential therapeutic activity of ErbB inhibitors in AT/RT.
authors.affiliation: Division of Pediatric Neurosurgery, Ann and Robert H. Lurie Children's Hospital of Chicago, 225 E. Chicago Avenue, Box # 28, Chicago, IL, 60611, USA, ssredni@luriechildrens.org.
authors.forename: Simone Treiger
authors.initials: ST
authors.lastname: Sredni
authors.forename: Kashyap
authors.initials: K
authors.lastname: Patel
authors.forename: Felipe
authors.initials: F
authors.lastname: D'Almeida Costa
authors.forename: Maria
authors.initials: M
authors.lastname: de Fátima Bonaldo
authors.forename: Tadanori
authors.initials: T
authors.lastname: Tomita
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D016543:Central Nervous System Neoplasms / Q000188:drug therapy* / Q000378:metabolism*; D066246:ErbB Receptors / Q000378:metabolism*; D005260:Female; D006801:Humans; D008297:Male; D011799:Quinazolines / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D011799:Quinazolines; D066246:ErbB Receptors